VION Biosciences, a life science platform company focused on specialty materials in the life science research, diagnostic, and drug discovery spaces, announces its second acquisition this August with the acquisition of Ansh Labs, a biotechnology company that focuses on the development, production, and distribution of high-quality immunoassay kits and reagents for research and clinical diagnostics. […]
You are unauthorized to view this page. Username Password Remember Me Forgot Password
Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it has entered into a definitive agreement to acquire privately-held Tantti Laboratory Inc. (“Tantti”) of Taoyuan City, Taiwan. Tantti has developed a unique portfolio of macroporous chromatography beads to optimize the purification of new modalities including viral vectors, viruses, nucleic
Repligen Announces Agreement to Acquire Chromatography Innovator Tantti Read More »
You are unauthorized to view this page.
Repligen Announces Agreement to Acquire Chromatography Innovator Tantti Read More »
Specialty Appliances (or the “Company”), a portfolio company of Reynolda Equity Partners (“Reynolda”), has acquired Ordont Orthodontic Appliance Lab (“Ordont”). Specialty Appliances is a leading orthodontic laboratory focused on the manufacturing and development of customized orthodontic and specialty dental appliances and the distribution of consumable orthodontic products. In business for over 40 years and serving
Reynolda Equity Portfolio Company Specialty Appliances Acquires Ordont Read More »
You are unauthorized to view this page.
Reynolda Equity Portfolio Company Specialty Appliances Acquires Ordont Read More »
Genomenon, a genomic intelligence company today announced its acquisition of the Clinical Knowledgebase (CKB) from The Jackson Laboratory (JAX). CKB is the leading curated variant database used for interpreting complex cancer genomic profiles by some of the world’s premier oncology labs. This strategic acquisition enables Genomenon to provide an unprecedented understanding of the genome, with
Veranex, the first purpose-built, integrated global service platform for the medtech industry, announced that it has acquired HORUS Scientific, a pathology and histology facility. This acquisition further solidifies Veranex’s global commitment by deepening its end-to-end service capabilities for medtech innovation. HORUS Scientific’s Director, Dr. James ‘Butch’ Stanley, DVM, MS, DACVP, has developed and implemented industry-leading
Veranex Acquires Leading Pathology and Histology Provider HORUS Scientific Read More »
You are unauthorized to view this page.
Veranex Acquires Leading Pathology and Histology Provider HORUS Scientific Read More »
